TNXP (Tonix Pharmaceuticals) Earnings per share growth rate in current year

Weak pricing power and dumping in competitive niches are weighing on quotes. The chart of annual EPS growth demonstrates the market's search for a fundamental balance, where 27.10 is recorded as the baseline value. Tonix Pharmaceuticals (TNXP) focuses on innovative fibromyalgia treatment through sleep restoration, while all drug production has been fully outsourced to third-party CMO partners.
Analytical breakdowns and data insights for company Tonix Pharmaceuticals Inc. (TNXP)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt and liquidity details:
Debt to Capital Tonix Pharmaceuticals|TNXP - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Tonix Pharmaceuticals Holding Corp.|TNXP - Company Aggregate Debts|Debts to Net Assets Tonix Pharma|TNXP - Company Long-Term Liabilities|Company Short-Term Indebtedness Tonix Pharmaceuticals|Intermediate Coverage Ratio tonixpharma.com
- net income and valuation multiples indicators:
TNXP - Company Net Income|Forward Earnings Tonix Pharmaceuticals|TNXP - P/E Multiple|Future Price to Earnings Multiple Tonix Pharmaceuticals|TNXP - PEG Multiple|EV/EBITDA Multiple Tonix Pharmaceuticals Holding Corp.|TNXP - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Tonix Pharmaceuticals|TNXP - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months tonixpharma.com|TNXP - Earnings growth in current year|Earnings growth forecast for next year Tonix Pharmaceuticals
- company sales and revenue statistics:
Fundamental valuation:TNXP - Tonix Pharmaceuticals

The year-over-year EPS comparison reflects the cost management efficiency of Tonix Pharmaceuticals (TNXP) amid heavy R&D spending pressure. This indicator measures the percentage change in net income per share, allowing investors to assess the capital burn rate and liquidity shortage risks in the absence of stable commercial revenues.
Key competitors
Earnings per share growth rate in current year Haleon Corp (HLN)|KVUE (Kenvue Inc) - Earnings growth in current year|Earnings per share growth rate in current year veronapharma.com VRNA|Earnings per share growth in current year Jyong Biotech (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Earnings per share increase in current year|Earnings growth in current year AMRX (Amneal Pharmaceuticals, Inc.)|PRGO (Perrigo Company) - Earnings per share trend in current year|ALVO - Earnings per share growth in current year|Expected net earnings per share growth this year liquidia.com LQDA|Galapagos (GLPG) - Earnings per share growth in current year|ANIP - Expected net earnings per share growth this year|Earnings per share growth in current year MannKind Corporation|AMPH: Earnings per share increase in current year|Earnings per share growth in current year Pacira BioSciences (PCRX)|SPRY: Earnings per share trend in current year|Theravance Biopharma, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year AQST (Aquestive Therapeutics, Inc.)|SCPH - Earnings per share growth in current year|Expected net earnings per share growth this year tectonictx.com TECX|SXTC (China SXT Pharmaceuticals) - Net earnings per share growth this year|Eupraxia Pharmaceuticals (EPRX) - Earnings growth in current year|Earnings per share growth in current year BioHarvest Sciences, Inc.|EXOZ: Earnings per share increase in current year|Earnings growth in current year ORMP|ENTX - Earnings per share growth rate in current year|Earnings per share growth in current year MindWalk Holdings, Inc. HYFT|Earnings growth in current year abvcpharma.com ABVC|CPIX - Earnings per share growth in current year|Earnings per share trend in current year QNTM|FGEN (FibroGen Corporation) - Net earnings per share growth this year|Net earnings per share growth this year Telomir Pharma|Net earnings per share growth this year RANI|Earnings per share growth rate in current year synergychc.com SNYR|Earnings per share growth in current year Rallybio Corp (RLYB)|LEXX - Earnings per share growth rate in current year|Pulmatrix Inc - Net earnings per share growth this year|Earnings per share increase in current year PTHL|Aptorum Group Ltd - Earnings growth in current year|Expected net earnings per share growth this year Lyra Therapeutics LYRA|IBO: Earnings growth in current year|TNFA (TNF Pharma) - Earnings per share growth in current year|Earnings per share growth in current year cbdmd.com|Earnings per share growth this year PRFX (PainReform Corp)|Earnings growth in current year CYTO|Net earnings per share growth this year Lipella Pharmaceuticals LIPO|Earnings per share growth in current year OptiNose OPTN|Pieris Pharmaceuticals Inc - Earnings per share growth in current year|Procaps Group Corp - Earnings growth in current year|Expected net earnings per share growth this year Petros Pharma PTPI|Qilian International Holding Group Limited (QLI) - Earnings per share growth in current year|ACELYRIN (SLRN) - Earnings growth in current year|Earnings per share growth in current year TFF Pharmaceuticals